arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

USANA HEALTH SCIENCES INC

USNA
$15.45 ▲ +0.58 (+3.90%) at close
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
67 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
56
Health
Fair
Neutral
auto_awesome

Analytical Summary

USANA HEALTH SCIENCES INC shows mixed fundamentals. Consider comparing against peers in the Materials sector before making investment decisions.

Market Cap $284.2M
Dividend Yield
Revenue Growth 0.3%
Op. Margin 5.5%
ROIC 1.1%
FCF / Share $0.39
Trailing P/E 37.7x
Price / Book 0.5x
FCF Yield 2.5%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$250.22M
— +0.3%
Net Income Profit after all expenses
$7.51M
↓ -20.1%
Operating Margin Operating profit as % of sales
5.5%
↑ +228.4% 40th
FCF / Share Free cash flow per share
$0.39
↓ -41.9%

Health Breakdown

Profitability
34
Returns
47
Financial Health
94
Cash Quality
53

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters